T.-C Wu - Publications

Johns Hopkins University, Baltimore, MD 
Immunology, Molecular Biology, Cell Biology

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Park JH, Jang JH, Choi EJ, Kim YS, Lee EJ, Jung ID, Han HD, Wu TC, Hung CF, Kang TH, Park YM. Annexin A5 increases survival in murine sepsis model by inhibiting HMGB1-mediated pro-inflammation and coagulation. Molecular Medicine (Cambridge, Mass.). 22. PMID 27447360 DOI: 10.2119/molmed.2016.00026  0.32
2016 Lee SJ, Yang A, Wu TC, Hung CF. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research. Journal of Gynecologic Oncology. e51. PMID 27329199 DOI: 10.3802/jgo.2016.27.e51  0.32
2016 Yang MC, Yang A, Qiu J, Yang B, He L, Tsai YC, Jeang J, Wu TC, Hung CF. Buccal injection of synthetic HPV long peptide vaccine induces local and systemic antigen-specific CD8+ T-cell immune responses and antitumor effects without adjuvant. Cell & Bioscience. 6: 17. PMID 26949512 DOI: 10.1186/s13578-016-0083-9  0.32
2016 Peng S, Qiu J, Yang A, Yang B, Jeang J, Wang JW, Chang YN, Brayton C, Roden RB, Hung CF, Wu TC. Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease. Cell & Bioscience. 6: 16. PMID 26918115 DOI: 10.1186/s13578-016-0080-z  0.32
2016 Yang A, Jeang J, Cheng K, Cheng T, Yang B, Wu TC, Hung CF. Current State in the Development of Candidate Therapeutic HPV Vaccines. Expert Review of Vaccines. PMID 26901118 DOI: 10.1586/14760584.2016.1157477  0.32
2016 Peng S, Mattox A, Best SR, Barbu AM, Burns JA, Akpeng B, Jeang J, Yang B, Ishida E, Hung CF, Wu TC, Pai SI. Identification of the murine H-2D(b) and human HLA-A*0201 MHC class I-restricted HPV6 E7-specific cytotoxic T lymphocyte epitopes. Cancer Immunology, Immunotherapy : Cii. PMID 26759151 DOI: 10.1007/s00262-016-1793-x  0.32
2015 Alvarez RD, Huh WK, Bae S, Lamb LS, Conner MG, Boyer J, Wang C, Hung CF, Sauter E, Paradis M, Adams EA, Hester S, Jackson BE, Wu TC, Trimble C. A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3). Gynecologic Oncology. PMID 26616223 DOI: 10.1016/j.ygyno.2015.11.026  0.32
2015 Sun YY, Peng S, Han L, Qiu J, Song L, Tsai YC, Yang B, Roden RB, Trimble CL, Hung CF, Wu TC. Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T Cell Mediated Tumor Control in the Genital Tract. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26420854 DOI: 10.1158/1078-0432.CCR-15-0234  0.32
2015 Wu CC, Yang YC, Hsu YT, Wu TC, Hung CF, Huang JT, Chang CL. Nanoparticle-induced intraperitoneal hyperthermia and targeted photoablation in treating ovarian cancer. Oncotarget. PMID 26318039 DOI: 10.18632/oncotarget.4766  0.32
2015 Yang B, Yang A, Peng S, Pang X, Roden RB, Wu TC, Hung CF. Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination. Cell & Bioscience. 5: 35. PMID 26113972 DOI: 10.1186/s13578-015-0025-y  0.32
2015 Sun Y, Peng S, Qiu J, Miao J, Yang B, Jeang J, Hung CF, Wu TC. Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors. Gene Therapy. 22: 528-35. PMID 25786869 DOI: 10.1038/gt.2015.17  0.32
2015 Lee SJ, Song L, Yang MC, Mao CP, Yang B, Yang A, Jeang J, Peng S, Wu TC, Hung CF. Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation. Vaccine. 33: 1549-55. PMID 25701675 DOI: 10.1016/j.vaccine.2015.02.019  0.32
2015 Huang Z, Peng S, Knoff J, Lee SY, Yang B, Wu TC, Hung CF. Combination of proteasome and HDAC inhibitor enhances HPV16 E7-specific CD8+ T cell immune response and antitumor effects in a preclinical cervical cancer model. Journal of Biomedical Science. 22: 7. PMID 25591912 DOI: 10.1186/s12929-014-0111-1  0.32
2015 Peng S, Wang JW, Karanam B, Wang C, Huh WK, Alvarez RD, Pai SI, Hung CF, Wu TC, Roden RB. Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer. Plos One. 10: e116389. PMID 25560237 DOI: 10.1371/journal.pone.0116389  0.32
2015 Tsen SW, Donthi N, La V, Hsieh WH, Li YD, Knoff J, Chen A, Wu TC, Hung CF, Achilefu S, Tsen KT. Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment. Journal of Biomedical Optics. 20: 051008. PMID 25423046 DOI: 10.1117/1.JBO.20.5.051008  0.32
2014 Yang B, Jeang J, Yang A, Wu TC, Hung CF. DNA vaccine for cancer immunotherapy. Human Vaccines & Immunotherapeutics. 10: 3153-64. PMID 25625927 DOI: 10.4161/21645515.2014.980686  0.32
2014 Song L, Yang MC, Knoff J, Wu TC, Hung CF. Cancer immunotherapy employing an innovative strategy to enhance CD4+ T cell help in the tumor microenvironment. Plos One. 9: e115711. PMID 25531529 DOI: 10.1371/journal.pone.0115711  0.32
2014 Song L, Yang MC, Knoff J, Sun ZY, Wu TC, Hung CF. Cancer immunotherapy using a potent immunodominant CTL epitope. Vaccine. 32: 6039-48. PMID 25245934 DOI: 10.1016/j.vaccine.2014.09.021  0.32
2014 Kang TH, Knoff J, Yeh WH, Yang B, Wang C, Kim YS, Kim TW, Wu TC, Hung CF. Treatment of tumors with vitamin E suppresses myeloid derived suppressor cells and enhances CD8+ T cell-mediated antitumor effects. Plos One. 9: e103562. PMID 25072795 DOI: 10.1371/journal.pone.0103562  0.32
2014 Soong RS, Song L, Trieu J, Knoff J, He L, Tsai YC, Huh W, Chang YN, Cheng WF, Roden RB, Wu TC, Trimble CL, Hung CF. Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5456-67. PMID 24893628 DOI: 10.1158/1078-0432.CCR-14-0344  0.32
2014 Yang M, Yu T, Wood J, Wang YY, Tang BC, Zeng Q, Simons BW, Fu J, Chuang CM, Lai SK, Wu TC, Hung CF, Hanes J. Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model. Drug Delivery and Translational Research. 4: 203-9. PMID 24816829 DOI: 10.1007/s13346-013-0190-7  0.32
2009 Rowley J, Monie A, Hung CF, Wu TC. Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8+ T cells modifies adoptively transferred T-cell function in cis. European Journal of Immunology. 39: 491-506. PMID 19180469 DOI: 10.1002/eji.200838594  0.32
2008 Rowley J, Monie A, Hung CF, Wu TC. Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans. Journal of Immunology (Baltimore, Md. : 1950). 181: 8237-47. PMID 19050240  0.32
2007 Lin KY, Lu D, Hung CF, Peng S, Huang L, Jie C, Murillo F, Rowley J, Tsai YC, He L, Kim DJ, Jaffee E, Pardoll D, Wu TC. Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion. Cancer Research. 67: 1832-41. PMID 17308126 DOI: 10.1158/0008-5472.CAN-06-3014  0.32
Show low-probability matches.